Farmácia clínica em oncologia
Cunha, Carlos Henrique Moreira da.
Rio de Janeiro; INCA; 2016.
Não convencional em Inglês, Português | Coleciona SUS | ID: sus-31756
Genetic assessment of breast cancer risk in primary care practice.
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.
Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.
Breast cancer specialists' views on and use of risk prediction models in clinical practice: a mixed methods approach.
Longitudinal trajectory of sexual functioning after hematopoietic cell transplantation: impact of chronic graft-versus-host disease and total body irradiation.
Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes: lingering uncertainties and emerging possibilities.
Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.
Does random treatment assignment cause harm to research participants?
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial.
"It's not like judgment day": public understanding of and reactions to personalized genomic risk information.